Treatment of Sub-capital Fractures of Hip Joint by Using TriboFit™ Acetabular Buffer

NCT ID: NCT00663468

Last Updated: 2020-02-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

11 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-04-30

Study Completion Date

2009-09-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine the performance and efficacy during 6 and 12 month post operation.

1. determine changes in patient pain level
2. determine changes in patient functionality
3. determine changes in patient life quality

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hip Fractures

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female or male that is not younger than 60 years old.
* Patient suffers from hip fracture that will need hip arthroplasty.
* Patient that weight less than 150Kg
* Patient femur head diameter between 40mm - 50mm
* Mentally normal
* Patient that could walk before suffering from hip fracture
* Patient that willing to cooperate with the doctor
* Patient that signed on the acceptance form

Exclusion Criteria

* Patient that does not willing to cooperate with the doctor
* Patient that is legally rejected
* Patient that suffer from cancer
* Patient that had passed amputation in is limbs
* Patient that is paralysis
* Patient that passed CVA or TIA
* Patient that still recovering from hard wounds or surgery
* Patient that suffer from infection in the hip joint
Minimum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Active Implants

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TLV-0021-08

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.